Valuation: Cogstate Limited

Market Cap 476M 337M 291M 274M 249M 468M 32.25B 3.21B 1.25B 16.15B 1.27B 1.24B 53.66B P/E 2026 *
28.5x
P/E 2027 * 20.9x
Enterprise Value 419M 297M 256M 241M 219M 412M 28.37B 2.82B 1.1B 14.21B 1.11B 1.09B 47.21B EV / Sales 2026 *
4.81x
EV / Sales 2027 * 3.94x
Free-Float
54.18%
Yield 2026 *
1.17%
Yield 2027 * 1.46%

Last Transcript: Cogstate Limited

1 day+2.19%
1 week+8.11%
Current month+12.00%
1 month+0.72%
3 months+11.55%
6 months+29.03%
Current year+23.89%
1 week 2.59
Extreme 2.59
2.8
1 month 2.42
Extreme 2.42
2.8
Current year 2.01
Extreme 2.01
3.01
1 year 1.65
Extreme 1.65
3.01
3 years 0.8
Extreme 0.795
3.01
5 years 0.8
Extreme 0.795
3.01
10 years 0.16
Extreme 0.155
3.01
Manager TitleAgeSince
Chief Tech/Sci/R&D Officer - 1999-12-16
Chief Executive Officer - 2005-11-30
Director of Finance/CFO - 2021-01-31
Director TitleAgeSince
Director/Board Member - 2011-02-28
Chairman 67 2009-11-02
Director/Board Member - 2017-01-19
Date Insider Type Main position Quantity % Market Cap.
12/24/25 Buy

Director

10,183 0.0059%
11/2/25 Free

Chief Executive Officer

591,822 0.3448%
10/19/25 Fiscal year

Chief Executive Officer

399,500 0.2324%
Change 5-day change 1-year change 3-year change Capi.($)
+2.19%+8.11%+69.18%+92.44% 337M
-1.78%-1.68%+1.99%+13.84% 48.42B
+0.85%-0.70%+465.55%+579.03% 43.66B
-2.40%-0.23%+12.20%+70.22% 39.51B
-2.01%-0.85%+24.95%+7.51% 38.95B
-0.50%+0.85%+20.60%+49.65% 32.61B
+0.38%-3.23% - - 16.32B
-0.59%-2.06%+26.13%+117.79% 16.15B
+0.49%+0.92%+4.32%+22.16% 14.16B
-0.43%+4.70%+79.75%+29.11% 13.37B
Average -0.38%+0.86%+78.30%+109.09% 26.35B
Weighted average by Cap. -0.91%+0.59%+97.60%+134.63%

Financials

2026 *2027 *
Net sales 86.95M 61.64M 53.24M 50.03M 45.5M 85.54M 5.89B 586M 229M 2.95B 231M 226M 9.81B 102M 72.49M 62.61M 58.83M 53.51M 101M 6.93B 689M 270M 3.47B 272M 266M 11.54B
Net income 16.9M 11.98M 10.35M 9.72M 8.84M 16.62M 1.15B 114M 44.54M 574M 44.98M 44M 1.91B 22.92M 16.25M 14.04M 13.19M 11.99M 22.55M 1.55B 155M 60.42M 778M 61.01M 59.69M 2.59B
Net Debt -57.17M -40.53M -35.01M -32.89M -29.92M -56.24M -3.88B -385M -151M -1.94B -152M -149M -6.45B -72.31M -51.26M -44.28M -41.61M -37.84M -71.14M -4.9B -487M -191M -2.45B -192M -188M -8.16B
Logo Cogstate Limited
Cogstate Limited is a neuroscience technology company optimizing brain health assessments to advance the development of new medicines and to enable earlier clinical insights in healthcare. Its principal activities are the creation, validation, and commercialization of digital brain health assessments; and design and provision of quality assurance services in clinical trials, focused on the administration, scoring, and recording of conventional brain health assessments. Its segments include Clinical Trials, Healthcare, and Administration. In the Clinical Trials segment, the technology and associated services are used to quantify the effect of disease and of drugs, devices or other interventions on human subjects participating in clinical trials primarily conducted by pharmaceutical, and biotechnology companies. In the Healthcare segment, the technology and associated services are being developed as a tool for primary care physicians and/or hospitals to assess cognitive decline.
Employees
160
Date Price Change Volume
26-08-14 A$2.800 +2.19% 1,292,674
26-08-13 A$2.740 -0.36% 849,793
26-08-12 A$2.750 +1.85% 1,003,455
26-08-11 A$2.700 +1.12% 237,911
26-08-10 A$2.670 +3.09% 64,109
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
2.800AUD
Average target price
3.540AUD
Spread / Average Target
+26.43%

Quarterly revenue - Rate of surprise